The PE ratio for Lifevantage stock stands at 19.67 as of Jun 12, 2026. The calculation is based on the latest EPS of $0.46 and the stock price of $9.05 per share. An increase of 66% has been observed in the PE ratio compared to its average of 11.8 of the past four quarters.
Over the last ten years, the average PE ratio of Lifevantage has been 22.69. The current 19.67 price-to-earnings ratio is 13% less than the historical average. Analyzing the last ten years, LFVN's PE ratio reached its highest point in the Sep 2022 quarter at 75, with a price of $3.75 and an EPS of $0.05. The Mar 2022 quarter saw the lowest point at 6.7, with a price of $4.76 and an EPS of $0.71.
Maximum annual increase: 325.17% in 2016
Maximum annual decrease: -59.44% in 2014
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 16.35 | -38.88% | $13.08 | $0.8 |
| 2024 | 26.75 | 22.99% | $6.42 | $0.24 |
| 2023 | 21.75 | 19.97% | $4.35 | $0.2 |
| 2022 | 18.13 | 126.91% | $4.35 | $0.24 |
| 2021 | 7.99 | -51.55% | $7.35 | $0.92 |
| 2020 | 16.49 | -32.67% | $13.52 | $0.82 |
| 2019 | 24.49 | 57.59% | $12.98 | $0.53 |
| 2018 | 15.54 | -56.93% | $6.37 | $0.41 |
| 2017 | 36.08 | 16.73% | $4.33 | $0.12 |
| 2016 | 30.91 | 325.17% | $13.6 | $0.44 |
| 2015 | 7.27 | -45.91% | $3.71 | $0.51 |
| 2014 | 13.44 | -59.44% | $10.08 | $0.75 |
| 2013 | 33.14 | 40.54% | $16.24 | $0.49 |
| 2012 | 23.58 | N/A | $19.81 | $0.84 |
| 2011 | N/A | N/A | $10.5 | -$4.83 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 9.39 | -3.99% | $4.32 | $0.46 |
| Dec 2025 | 9.78 | -17.61% | $6.16 | $0.63 |
| Sep 2025 | 11.87 | -27.4% | $9.73 | $0.82 |
| Jun 2025 | 16.35 | -15.9% | $13.08 | $0.8 |
| Mar 2025 | 19.44 | -33.47% | $14.58 | $0.75 |
| Dec 2024 | 29.22 | -17.76% | $17.53 | $0.6 |
| Sep 2024 | 35.53 | 32.82% | $12.08 | $0.34 |
| Jun 2024 | 26.75 | 23.79% | $6.42 | $0.24 |
| Mar 2024 | 21.61 | -17.17% | $6.05 | $0.28 |
| Dec 2023 | 26.09 | -19.1% | $6 | $0.23 |
| Sep 2023 | 32.25 | 48.28% | $6.45 | $0.2 |
| Jun 2023 | 21.75 | N/A | $4.35 | $0.2 |
| Mar 2023 | N/A | N/A | $3.59 | -$0.05 |
| Dec 2022 | N/A | N/A | $3.72 | -$0.04 |
| Sep 2022 | 75 | 313.68% | $3.75 | $0.05 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, LFVN's PE ratio is under its 3, 5 and 10-year averages.
With a price to earnings (P/E) of 19.67, LFVN stands higher than the industry average but lower than the Consumer Defensive sector average. Looking at the Consumer Defensive sector average of 21.99, Lifevantage's price to earnings (P/E) is 11% lower.
LFVN's PE ratio is less than its peer stock USNA, but it is above NATR's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| LFVN Lifevantage Corp | 14.37 | $83.39M |
| NATR Natures Sunshine Products Inc | 18.05 | $352.4M |
| USNA Usana Health Sciences Inc | 40.44 | $358.37M |
| OGEN Oragenics Inc | N/A | $2.82M |
| MTEX Mannatech Inc | N/A | $10.89M |
As of Jun 12, 2026, LFVN stock has a price to earnings ratio of 19.67.
As an average over the last 3 years, LFVN stock has a PE ratio of 21.67.
As an average over the last 5 years, LFVN stock has a PE ratio of 21.29.
Over the last ten years, the quarterly PE ratio reached its highest level at 75 in the Sep 2022 quarter.
LFVN's current price to earnings ratio is 13% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 12, 2026), Lifevantage's share price is $9.05. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.46. Therefore, Lifevantage's price to earnings ratio for today is 19.67. PE RATIO(19.67) = STOCK PRICE($9.05) / TTM EPS($0.46)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.